Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Salvarani

Showing results (21-30 of 624) with videos related to

Pageof 63
Sort By:
Lancet (London, England)|January 24, 2006
Retroperitoneal fibrosisAugusto Vaglio, Carlo Salvarani, Carlo Buzio
Clinical and Experimental Rheumatology|May 30, 2012
Recommendations of the Italian Society of Rheumatology for the treatment of the primary large-vessel vasculitis with biological agentsNicolò Pipitone, Ignazio Olivieri, Carlo Salvarani, et al.
Current Opinion in Rheumatology|March 3, 2023
The role of PET/CT in disease activity assessment in patients with large vessel vasculitisElena Galli, Nicolò Pipitone, Carlo Salvarani
Current Opinion in Rheumatology|December 3, 2010
Chronic periaortitis: a large-vessel vasculitis?Augusto Vaglio, Nicolò Pipitone, Carlo Salvarani
The Journal of Rheumatology|November 3, 2018
Cardiac and Pulmonary Artery Involvement Detected by 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Large-vessel Giant Cell ArteritisRaffaella Ugolini, Francesco Muratore, Carlo Salvarani
Clinical and Experimental Rheumatology|October 17, 2015
Cyclosporine in psoriatic arthropathyAlessandra Soriano, Nicolò Pipitone, Carlo Salvarani
The Lancet. Respiratory Medicine|November 14, 2022
Rituximab for connective tissue disease-associated interstitial lung diseaseAndreina Manfredi, Carlo Salvarani, Marco Sebastiani
Expert Review of Clinical Immunology|January 25, 2017
Standard and biological treatment in large vessel vasculitis: guidelines and current approachesFrancesco Muratore, Nicolò Pipitone, Carlo Salvarani
European Journal of Nuclear Medicine and Molecular Imaging|November 20, 2016
Do we need FDG-PET/CT to assess atherosclerosis?Nicolò Pipitone, Carlo Salvarani, Annibale Versari
The Journal of Rheumatology|January 3, 2013
Is (18)F fluorodeoxyglucose positron emission tomography useful to assess activity of myositis?Nicolò Pipitone, Annibale Versari, Carlo Salvarani
Pageof 63

Showing results (21-30 of 624) with videos related to

Sort By:
Pageof 63
Lancet (London, England)|January 24, 2006
Retroperitoneal fibrosisAugusto Vaglio, Carlo Salvarani, Carlo Buzio
Clinical and Experimental Rheumatology|May 30, 2012
Recommendations of the Italian Society of Rheumatology for the treatment of the primary large-vessel vasculitis with biological agentsNicolò Pipitone, Ignazio Olivieri, Carlo Salvarani, et al.
Current Opinion in Rheumatology|March 3, 2023
The role of PET/CT in disease activity assessment in patients with large vessel vasculitisElena Galli, Nicolò Pipitone, Carlo Salvarani
Current Opinion in Rheumatology|December 3, 2010
Chronic periaortitis: a large-vessel vasculitis?Augusto Vaglio, Nicolò Pipitone, Carlo Salvarani
The Journal of Rheumatology|November 3, 2018
Cardiac and Pulmonary Artery Involvement Detected by 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Large-vessel Giant Cell ArteritisRaffaella Ugolini, Francesco Muratore, Carlo Salvarani
Clinical and Experimental Rheumatology|October 17, 2015
Cyclosporine in psoriatic arthropathyAlessandra Soriano, Nicolò Pipitone, Carlo Salvarani
The Lancet. Respiratory Medicine|November 14, 2022
Rituximab for connective tissue disease-associated interstitial lung diseaseAndreina Manfredi, Carlo Salvarani, Marco Sebastiani
Expert Review of Clinical Immunology|January 25, 2017
Standard and biological treatment in large vessel vasculitis: guidelines and current approachesFrancesco Muratore, Nicolò Pipitone, Carlo Salvarani
European Journal of Nuclear Medicine and Molecular Imaging|November 20, 2016
Do we need FDG-PET/CT to assess atherosclerosis?Nicolò Pipitone, Carlo Salvarani, Annibale Versari
The Journal of Rheumatology|January 3, 2013
Is (18)F fluorodeoxyglucose positron emission tomography useful to assess activity of myositis?Nicolò Pipitone, Annibale Versari, Carlo Salvarani
Pageof 63